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The efficacy of tendon-derived stem cells (TDSCs) for the promotion of tendon and tendon-bone junction repair
has been reported in animal studies. Modulation of the tendon stem cell niche in vivo has also been reported to
influence tendon structure. There is a need to have specific and reliable markers that can define TDSCs in vitro and
tendon stem cells in situ for several reasons: to understand the basic biology of TDSCs and their subpopulations
in vitro; to understand the identity, niches and functions of tendon/progenitor stem cells in vivo; to meet the
governmental regulatory requirements for quality of TDSCs when translating the exciting preclinical findings into
clinical trial/practice; and to develop new treatment strategies for mobilizing endogenous stem/progenitor cells in
tendon. TDSCs were reported to express the common mesenchymal stem cell (MSC) markers and some embryonic
stem cell (ESC) markers, and there were attempts to use these markers to label tendon stem cells in situ. Are these
stem cell markers useful for the identification of TDSCs in vitro and tracking of tendon stem cells in situ? This review
aims to discuss the values of the panel of MSC, ESC and tendon-related markers for the identification of TDSCs
in vitro. Important factors influencing marker expression by TDSCs are discussed. The usefulness and limitations of
the panel of MSC, ESC and tendon-related markers for tracking stem cells in tendon, especially tendon stem cells, in
situ are then reviewed. Future research directions are proposed.Introduction: importance of labeling tendon-derived
stem cells in vitro and tracking stem cells in tendon
in situ
The discovery of tendon stem/progenitor cells in the
tendon mid-substance marks a new era for understanding
the physiology and pathology of tendon as well as devel-
oping innovative therapeutics for the treatment of tendon
and tendon-bone junction injuries [1]. Despite being
heterogeneous cell populations, there is a huge need for
markers to characterize and define the biological char-
acteristics of tendon-derived stem cells (TDSCs) or their
subpopulations in vitro, and to study the identity, niches
and functions of stem/progenitor cells in tendon in vivo.
This information is crucial for understanding the molecu-
lar/cellular mechanisms of tendon physiology and patholo-
gies, and hence developing effective treatment strategies.Correspondence: paulinelui00@gmail.com
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unless otherwise stated.Specific markers for quality control of TDSCs or their
subpopulations are currently lacking, yet are crucial for
the translation of research findings from bench to bed
under current good manufacturing practice. Likewise, the
functional modulation of stem/progenitor cells in tendon
is an interesting approach to promote tendon and tendon-
bone junction repair which may not require surgery, such
as in mild acute tendon injury and chronic tendinopathy.
The goal of modulating stem/progenitor cells in tendon is
currently hampered by the limited data about their iden-
tity, niches and functions in tendon. In this review, I aim
to update and discuss the future research directions of
markers for defining TDSCs in vitro and stem cells in ten-
don, particularly tendon stem cells, in vivo. The terms
‘tendon-derived stem cells (TDSCs)’ and ‘stem cells in
tendon’ refer to the stem/progenitor cells isolated from
tendon mid-substances in vitro and detected in situ, re-
spectively. The term ‘tendon stem cells’ refers to the
stem/progenitor cells that reside in, and hence are spe-
cific to, tendon mid-substances.Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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The Mesenchymal and Tissue Stem Cell Committee of
the International Society for Cellular Therapy has pro-
posed three minimal criteria to define human mesenchy-
mal stem cells (MSCs). Among these criteria, more than
95 % of the isolated cells should express CD105, CD73
and CD90, and less than 2 % of the cells should express
CD45, CD34, CD14 or CD11b, CD79a or CD19 and
HLA-DR [2]. TDSCs hence meet the marker require-
ment of the International Society for Cellular Therapy
for MSCs (Tables S1 and S2 in Additional file 1). They
express CD90, CD73 and CD105 but are negative for
CD31, CD34, CD45, HLA-DR, CD11b, CD14 and CD19
[3–5]. However, the International Society for Cellular
Therapy’s proposed markers cannot uniquely distinguish
TDSCs from other MSCs and some differentiated cells
[6]. Many MSC markers are in fact fibroblast markers
and the fibroblastic nature of MSCs, including TDSCs,
may explain their expression in both fibroblasts and
MSCs [7, 8]. Human skin or lung fibroblasts have been
reported to express CD105, CD166, CD90, CD44, CD29,
CD73 and CD9 as in human bone marrow-derived stem
cells (BMSCs) [9]. Tendon explant culture that con-
tained total tendon cells and mainly tenocytes expressed
CD44, CD73 and CD90 at similar percentages to
TDSCs, suggesting that these markers are not useful for
quality control of TDSCs in cell-based therapies (unpub-
lished observations). Rat tail tendon fibroblasts were also
shown to express CD44 [10]. Ruzzini and colleagues
prospectively purified CD44+ cells from human semiten-
dinosus tendons and reported that they were stem cells,
and speculated that the CD44– cells were tenocytes be-
cause they did not express CD146 and Stro-1 [11]. How-
ever, further study on the colony-forming ability and
multilineage differentiation potential of the tendon fibro-
blasts in these two studies is needed [10, 11]. Some infor-
mation about the CD markers’ functions is available
although their exact functions in stem cells are poorly
understood [12–14]. The crude definition of MSCs based
only on in vitro assays creates difficulties in identifying
specific markers for bona fide stem cells [15]. Better un-
derstanding of the in vivo functions of MSC markers in
TDSCs will rationalize and facilitate the selection of appro-
priate markers for distinguishing TDSCs from tenocytes.
Collagen type I, collagen type III, tenascin C, scleraxis
(Scx) and tenomodulin (Tnmd) are commonly used
tendon-related markers. They alone are also not useful
for distinguishing TDSCs from tenocytes because both
cell types express these markers. Stemness is not a frozen
condition but a continuous process. Hence we do not know
the point at which the expression of tenogenic markers
alone is associated with the loss of self-renewal and multi-
potency – the definition of terminal differentiation.TDSCs expressed very high levels of Scx, Tnmd and
Mohawk (Mkx) [16, 17]. Contrary to expectation, the loss
of Tnmd resulted in reduced clonogenicity and prolifera-
tive potential as well as earlier and higher incidence of cel-
lular senescence, but has no profound effect on the in vitro
multilineage differentiation potential of mouse TDSCs
[18]. Ectopic expression of Tnmd in wild-type mouse
TDSCs increased cell proliferation [18]. This apparently
contradicts the use of Tnmd as a tenogenic differentiation
maker and hence more sophisticated regulation of Tnmd
in stem cells is in place. Whether the loss of Scx is associ-
ated with increased or loss of stemness of TDSCs requires
further research. However, overexpression of Scx has been
associated with the loss of colony-forming ability, prolifera-
tion and in vitro multilineage differentiation potential of an
immortalized BMSC line [19]. Ectopic expression of Scx
combined with force has also been reported to synergistic-
ally promote the commitment of MSCs derived from hu-
man embryonic stem cells (ESCs) to tenocytes [20].
Ectopic Mkx expression has been reported to promote
lineage commitment and in vitro tenogenesis more effi-
ciently than Scx in a C3H10T1/2 mouse MSC line [17].
Overexpression of Mkx also enhanced expression of Scx
protein and mRNA, while silencing of Mkx downregulated
Scx, decorin (Dcn) and Tnmd mRNA expression in mouse
tail TDSCs [17]. Early growth response (Egr)1 was re-
ported to enhance the expression of tendon-related
markers and to inhibit in vitro nontenocyte differentiation
of rabbit TDSCs [21].
TDSCs have been reported to express Oct-4, Nanog,
nucleostemin, SSEA-4, c-myc and Sox2 [22–26] (Table
S1 in Additional file 1). These ESC markers might be
useful for distinguishing TDSCs from tenocytes because
a previous study has shown that tendon cells isolated
from culture after removal of TDSC colonies presented
limited in vitro multilineage differentiation potential and
did not express Oct-4, SSEA-4 and nucleostemin [26].
There has been no study directly comparing the expres-
sion of these ESC markers in TDSCs with the truly
pluripotent cells. Information demonstrating the causal
roles of these ESC markers in the self-renewal and multipo-
tency of TDSCs is also lacking. Further research in these
areas is required. Some ESC markers including Oct-4,
Nanog, nucleostemin and Sox2 are nuclear proteins that
limit their use as markers for prospective isolation of
TDSCs in clinical trials/practices. Surface markers such as
the SSEA families, if shown to be valid, might be more
useful for the prospective isolation of TDSCs.
Factors influencing marker expression by
tendon-derived stem cells
There are discrepancies in the expression of some
markers such as CD71, CD146, Stro-1, CD105 and
CD166 by TDSCs in different studies (Table S1 in
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influenced by the cell source, procedures of cell isolation
and cell culture.Cell source
Age
The age of the animal or human may affect the proper-
ties, including marker expression, of TDSCs. While
nearly 100 % of young and aged rat TDSCs expressed
nucleostemin, Oct-4 and SSEA-4, the aged TDSCs
expressed a lower percentage and cellular expression of
CD90.1 but a higher percentage and cellular expression
of CD44 compared with young cells [25]. On the other
hand, Kohler and colleagues reported no difference in
the expression of CD73, CD90, CD105, STRO-1, CD146
and Musashi-1 in young and healthy TDSCs compared
with aged and degenerated TDSCs isolated from human
nonruptured Achilles tendons [27]. Ruzzini and col-
leagues did not report any difference in the expression
of CD146 and STRO-1 with age in CD44+ TDSCs puri-
fied from healthy human semitendinosus tendon graft
[11]. However, the sample sizes in both of these studies
were small: n = 3 [27] and n = 2 [11] per age group. Fur-
ther research is needed to confirm the effect of age on
the properties, including marker expression, of TDSCs.Donors
The growth potential and immunophenotype of mouse
BMSCs have been reported to vary between strains [28].
Systematic study of the species-specific differences of
marker expression in TDSCs is lacking. The current lim-
ited research, however, has not identified a marker that
is exclusively present or absent in some species (Tables
S1 and S2 in Additional file 1). Markers that are
expressed across different species may have the highest
translational value.Tendon types
TDSCs isolated from different tendons may exhibit dif-
ferences in marker expression and hence functions.
Dyment and colleagues reported that patellar tendon
was the only tendon that has a mixture of both tendon
and ligament marker expression [29]. The generalization
of research findings (including TDSC markers, which
are the subject of this review) generated from patellar
tendon to other tendons therefore needs to be cautious.
Zhang and Wang reported that both patellar and Achilles
TDSCs expressed Oct-4, SSEA-4 and nucleostemin with-
out mentioning any differences in the expression levels
between these two cell sources [26]. More systematic in-
vestigation into the similarities and differences of TDSCs
isolated from different tendons are needed.Procedures of cell isolation
Contamination by stem/progenitor cells in neighboring
tissues
Contamination by stem/progenitor cells present in nearby
tissues is possible as TDSCs are isolated by enrichment.
This is especially an issue when the source tendon is
degenerated or injured. Nonhematopoietic adult stem
cells of different mesenchymal tissues probably express
a similar, although nonidentical, set of MSC and ESC
markers. They express some common markers because
they share fibroblast characteristics (see Markers charac-
terizing tendon-derived stem cells in vitro) and common
functions of stem cells. This implies that the use of com-
mon MSC and ESC markers which are not specifically
gauged to the tissue-specific functions of stem cells cannot
distinguish TDSCs from other MSCs.
A recent study has shown that mouse stem/progeni-
tors isolated from the peritenon and tendon proper were
Sca-1+, CD90.2+, CD44+, CD18– and CD133– [30], and
hence these markers cannot be used to distinguish them.
Another study has reported that peritenon cells isolated
from horse superficial digital flexor tendon expressed
higher mRNA level of cd45 (CD45), Thy1 (CD90), Eng
(CD105) and Oct4 as well as lower mRNA and protein
levels of Scx compared with cells isolated from the ten-
don proper [31]. Reparative mesenchymal cells have
been reported entering tendon after injury via blood cir-
culation [32]. P75+ neural-crest-like stem/progenitor
cells of perivascular origin have been reported to reside
within the peritenon and give rise to scar tissues follow-
ing patellar tendon injury in rats [33]. Another study has
also reported the migration of SMA+ cells in the perite-
non to the tendon injury site in the mid-substance, con-
tributing to tendon repair [29].
It is hypothesized that healing mediated by extraneous
cell populations (extrinsic healing) forms scar tissues
and adhesions while healing mediated by endogenous
cells (intrinsic healing) promotes tendon regeneration
[31, 34]. The ability to distinguish tendon stem/progeni-
tor cells from circulation-derived stem/progenitor cells
and neighboring tissues, particularly peritenon and ten-
don–bone junction, is therefore important. TDSCs
showed higher mRNA expression of Tnmd, Scx and Mkx
compared with other stem cells [16, 17, 30, 35]. A recent
study has reported that tendon proper-derived progeni-
tors expressed higher mRNA levels of Scx and trends
for Tnmd but a lower mRNA level of Emcn (a vascular
marker) compared with peritenon-derived progenitors
[36]. They have further shown that Scx protein (as
shown by green fluorescence protein (GFP) reporter)
was expressed in all cells in the tendon proper but not
in the cells of the surrounding peritenon of Achilles ten-
don of 1-day-old mouse [36]. A combination of tendon-
related markers and stem cell-specific markers (some
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for testing) may be able to distinguish TDSCs from
other MSCs and tenocytes.
Until specific TDSC markers are identified, the purity
of tissue used for TDSC isolation is critical for quality
control. The use of tendon from an injured or diseased
patient or a healthy donor for TDSC isolation is also
critical. Understanding the relationship of the potential
markers with the in vivo tendon-specific functions of
stem cells is essential for the identification of specific
markers distinguishing TDSCs from other MSCs.
Method of tissue digestion
The method of tissue digestion can potentially affect the
retention of antigenicity and the analysis of surface
markers [37]. Panchision and colleagues have reported
that CD24 antigenicity, which was retained after Liberase-
1 (a collagenase and neutral protease cocktail) and TrypLE
(a recombinant trypsin-like replacement) treatment, pro-
vided a useful discrimination of mouse fetal multipotent
stem cells from neuronal-committed progenitors and
post-mitotic neurons when paired with CD133 or CD15
[37]. However, this particular discrimination of the two in-
teresting cell subpopulations was not possible after papain
treatment of neural tissues because the expression of
CD24 was lost. Some research groups have used dis-
pase in addition to collagenase type I [3, 26], while
other groups have used collagenase type II [27, 38],
protease type XIV followed by collagenase B [31] or
collagenase type V [5] for tendon digestion for TDSC
isolation. The influence of the method of tissue diges-
tion on the subsequent surface marker analysis re-
quires further research.
Procedures of cell culture
Effect of culture conditions
Culture conditions can influence phenotypes, including
marker expression of TDSCs. Growth factors in fetal calf
serum, culture confluency, the topography and material
of the cell culture surface, mechanical loading and oxy-
gen tension can induce or suppress marker expression.
Human TDSCs cultured under 5 % oxygen expressed
higher levels of nucleostemin, Oct-4, Nanog and SSEA-4
as shown by immunohistochemistry and/or quantitative
RT-PCR [39]. Another study has shown that the surface
expression of CD44, CD73, CD90 and CD105 in human
TDSCs was maintained under hypoxia (2 % oxygen) as
shown by flow cytometry [40]. 2-Mercaptoethanol was
added to the initial cell culture for TDSC isolation in
some studies [3, 11, 30]. 2-Mercaptoethanol has been re-
ported to improve the culture environment by reducing
reactive oxygen species and to promote cell growth by
reducing cystine to cysteine needed for cell growth [41].
However, both 2-mercaptoethanol and cysteine havebeen reported in other studies as inducing agents for
neuronal-like cell differentiation in vitro [42, 43]. A re-
cent study has isolated neural crest-like stem/progenitor
cells from rat patellar tendon mid-substance by culturing
tendon-derived cells in an optimized neural crest
stem cell medium containing 2-mercaptoethanol [33].
The isolated cells expressed a panel of neural crest
stem cell markers (P75, vimentin, Snail, Sox10) in
addition to CD29 and CD90 [33]. They could also dif-
ferentiate into both mesenchymal (osteogenic, chondro-
genic, adipogenic and myogenic) and neural lineages
in vitro upon induction [33]. The use of neural crest
stem cell medium to culture tendon-derived cells might
create some selective pressure on cells and change their
fate commitment. There is currently no systematic
study of the effect of 2-mercaptoethanol on the bio-
logical characteristics including marker expression of
TDSCs.
Effect of cell passaging
The biological characteristics of many cell types
change after isolation from the in vivo environment
and in vitro passaging. The surface expression of CD90
and CD73 was downregulated during in vitro passaging
of rat patellar TDSCs [44]. CD146 was expressed in
some freshly isolated TDSCs but the expression was
lost after passaging [24], which explains the absence of
CD146 in TDSCs in our earlier study [40]. The use of
early and consistent cell passages for experiments and
trials is therefore recommended for reproducible out-
comes [44].
Markers for labeling tendon stem cells in situ
Many of the cues about the native frequency, niches and
functions of tendon stem cells are derived from TDSCs
which are defined and characterized in vitro. Most
in vitro markers are aimed originally to prospectively en-
rich the stem cell subset endowed with clonogenicity,
not to identify where the cells originated in the tissue.
The possibility exists that the phenotypes and functions
of TDSCs and tendon stem cells in vivo differ due to the
isolation of TDSCs from their native environment and
culture conditions that may alter their characteristics. In
contrast to the previous finding of high CD44 expression
on culture-expanded MSCs, Qian and colleagues found
that BMSCs physiologically did not express CD44 [45].
In vitro culture could result in the acquisition of CD44
expression and changes in the expression of cytokines,
growth factors, matrix proteins and other signaling mol-
ecules [45]. While CD44 and Sca-1 are used as in vitro
stem cell markers of TDSCs, nearly all of the cells in rat
patellar tendon were labeled in situ [24] and hence they
are not good in vivo markers. One study has reported
the labeling of stem cells in rat Achilles tendon in situ
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and the density of nucleostemin-positive cells was
twice as high at the tendon–calcaneus junction com-
pared with that at the tendon mid-substance [46].
However, another study has shown that nucleostemin
and other ESC markers (Oct-4, Nanog and Sox2) were
absent in all cells, including the iododeoxyuridine
(IdU) label-retaining cells, in intact rat patellar tendon
as shown by immunohistochemical staining [24]. How-
ever, these ESC markers were expressed in most of the
label-retaining cells in injured tendon in vivo and in
TDSCs in vitro [24], suggesting that the developmental
program might be reactivated during tendon injury.
Caution has to be taken when extrapolating the in vitro
findings to in vivo conditions.
Because the existing in vitro markers do not work
well in vivo, other methods are sought to track the
stem cells in vivo. Prelabeling of a specific cell popula-
tion in vivo with true stemness markers or lineage-
specific markers, combined with spatial information as
provided by histology or microdissection as well as
more frequent follow-up (sampling), may help to dis-
sect the cell sources and mechanisms for tendon re-
pair. Using the IdU labeling-retaining method, Bi and
colleagues [3] and Tan and colleagues [24] tried to
label the stem cells in tendon in situ. One potential
limitation of the IdU label-retaining method is that it
is not specific for tendon stem cells and all stem cells
in the body are labeled. The sources of stem cells that
contribute to different physiological or pathological
processes in tendon cannot be distinguished.
Beside the IdU label-retaining method, the detection
of telomerase-positive cells [47] and genetic-based
lineage tracing using tissue-specific developmental pro-
teins [48] may be useful for tracing stem cells in general
and tendon stem cells, respectively. Developmental
markers including Sox and sonic hedgehog have been
used for tracing skin progenitor cells [49] and post-
mitotic precursors of taste cells [50], respectively, in situ.
Tnmd and Scx are important proteins for tendon devel-
opment [51, 52]. Both the active form of Smad8, in the
presence of BMP2, and Scx have been reported to drive
the tenogenic reprogramming of immortalized BMSC
lines [19, 53]. However, most cells in intact adult tendon
expressed Scx, Tnmd and Smad8 [24], making it impos-
sible to use these markers to track the fate of tendon
stem cells in situ. Whether tendon developmental pro-
teins including Mkx, Egr1, Egr2, Eya1, Eya2, Six1, Six2,
Epha4 and Thbs4 can be used for tracing tendon stem
cells in situ requires further research.
Using the genetic-based lineage tracing technique,
Sox9-expessing precursors have been reported as the
cellular origin for cruciate ligament of the knee joint
and limb tendons [54]. Using a similar lineage tracingtechnique for tracking Sox9+ progenitors, another study
has reported that tendon cells were derived from Scx
+/Sox9+ and Scx+/Sox9– progenitors [55]. The closer the
tendon was to the cartilaginous junction, the more ten-
don cells arose from the Scx+/Sox9+ progenitors [55].
Dyment and colleagues used an inducible Cre driven by
alpha-smooth muscle actin (α-SMA, a marker for vascular
muscle cells and myofibroblasts) and a constitutively ac-
tive Cre driven by growth differentiation factor-5 (GDF5,
a chondrogenic and tenogenic factor), in combination
with a Cre reporter to trace SMA+ and GDF5+ popula-
tions and their progeny in mice [29]. They reported that
SMA+ cells were found in the peritenon, as well as in the
Scx+ cells within tendon mid-substance and myotendi-
nous junction, but they were not found in tendon entheses
or knee ligaments. In contrast, GDF5+ cells were found in
tendon entheses and knee ligaments. Using the SMA+
lineage marker, they have reported that SMA+ cells mi-
grated to the tendon injury site in the mid-substance and
differentiated into Scx+ cells [29]. Further studies are re-
quired to confirm that the isolated SMA+ population, in-
cluding the SMA+Scx+ population in tendon, and the
GDF5+ population are stem/progenitor cells by showing
their self-renewal and multilineage differentiation poten-
tial and by showing their effects on tendon development
with conditional inactivation/activation. Tracking of the
lineage of hedgehog-responsive cells based on Gli1 ex-
pression showed that a unique population of hedgehog-
responsive cells originated from the developing enthesis
was necessary for fibrocartilage progenitor cell differen-
tiation and eventually fibrocartilage mineralization in
the enthesis in adults [56]. Similar to the IdU label-
retaining method, the detection of telomerase activity is
not specific to tendon stem cells. The genetic-based
lineage tracing method has the advantage of being more
specific if useful developmental markers can be found.
The combined use of transgenic animals with cells la-
beled in different colors and cell transplantation may
facilitate the tracking of specific stem/progenitor cell
populations in situ, although exogenous cells are used
and hence this may raise concerns about their relevance
to the understanding of the physiological and natural
healing or injury processes. Using the CD-1 mouse
model, the CD-1 nude mouse model, the red fluores-
cent protein transgenic mouse model, the GFP trans-
genic mouse model, the Scx–GFP reporter mouse
model and the compound Scx–GFP reporter–red fluor-
escent protein mouse model, Asai and colleagues have
shown that two populations of stem/progenitor cells
isolated from injured tendons had distinct potentials
to participate in tendon regeneration and chondroid
degeneration after transplantation to the injury site,
although the origins of these cells were not eluci-
dated in the study [35].
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Understanding in vivo functions of common MSC and ESC
markers of tendon-derived stem cells
Markers defining the properties of bona fide stem cells
can only be identified through the use of in vivo assays
which functionally define stem cells [15]. While TDSCs
expressed many of the common MSC markers and some
ESC markers, the exact functions of these markers in
TDSCs are still poorly understood. Better understanding
of their in vivo functions using overexpression and knock-
down approaches as well as transplantation in null mouse
models are important to better select markers associated with
stemness (that is, self-renewal and multipotency) of TDSCs.
High-throughput technologies for distinguishing
tendon-derived stem cells from nonhematopoietic adult
stem cells of other mesenchymal tissues and tenocytes
High-throughput technologies such as single-cell gen-
ome analysis and transcriptome analysis of cultures of
TDSCs, tenocytes and nonhematopoietic adult stem cells
of other mesenchymal tissues can be used to search for
correlated gene clusters to classify cell types, dissect cell
heterogeneity, map out cellular hierarchy and construct
genetic networks [57–61]. Using a single-cell quantita-
tive PCR technique, Guo and colleagues have designed
an analysis platform to cover all commonly used cell
surface markers with a total of 280 genes for all mouse
cell types [57]. Hierarchical clustering of the single-cell
data faithfully grouped stem cells of the same origin to-
gether and revealed some lineage-specific markers. Using
the same platform, the authors further analyzed the gene
expression in all key cell populations of the mouse
hematopoietic system and hierarchically mapped out the
mouse hematopoietic system and hematopoietic stem cell
differentiation stages [57]. The clustering pattern may then
be used to identify novel markers and populations [57].
Using genome-wide gene expression analysis, Kaltz and
colleagues have shown that BMSCs are distinct from um-
bilical vein stromal cells [59]. Novel membrane-associated
markers were identified in BMSCs when compared with
umbilical vein stromal cells [59]. Mathematical models
based on DNA methylation of biomarkers have been re-
ported to distinguish induced pluripotent stem cells, ESCs
and somatic cells with high accuracy [61]. High-throughput
cell surface antigen profiling using an antibody array may
also be useful for the identification of specific TDSC surface
markers [62, 63]. In all cases, confirmation of the in vivo
functions of potential markers identified by these high-
throughput technologies is needed.
Characterization of tendon-derived stem cell subpopulations
with coexpressed markers
As heterogeneous cell populations, the identification of a
single marker that can specifically define TDSCs is expectedto be unfeasible. The current use of multiple single markers
for their identification therefore has limitations because
the markers may not be coexpressed by the same cell. The
characterization of TDSCs and their subpopulations using
hierarchical and coexpressed markers should be one re-
search direction. Flow cytometry supports the simul-
taneous detection of multiple markers, which facilitates
TDSC characterization and quality control. Flow cytomet-
ric analysis of marker expression in stem cells can be chal-
lenging as there is often no clear distinction between
positive and negative populations [64]. Much attention
therefore needs to be put on the correct gating during
flow cytometric analysis. Tormin and colleagues sorted
BMSCs based on their proliferation characteristics and
identified surface markers for the characterization of these
BMSC subpopulations by gene expression profiling [65].
Gauged by the Sca-1-positive signal, the CD105+ and
CD105– subpopulations of stem/progenitor cells were
found to show higher potentials in tendon regeneration
and chondroid degeneration, respectively, after transplant-
ation in the injured mouse Achilles tendon [35].
Labeling tendon stem cells in situ
Better understanding of the tendon induction and differ-
entiation during development would help the discovery
of specific markers for lineage tracing [66, 67]. The study
of the usefulness of tendon developmental proteins in-
cluding Mkx, Egr1, Egr2, Eya1, Eya2, Six1, Six2, Epha4
and Thb4 for tracing endogenous tendon stem cells
should be one research direction. Methods such as the
IdU label-retaining method, staining for telomerase and
measurement of telomerase activity are not specific for
labeling tendon stem cells but are useful for distinguish-
ing stem cells from terminally differentiated cells. When
combined with the spatial information in histology and
immunohistochemical staining of tendon-related markers
such as Scx and Tnmd, these methods are useful for tra-
cing stem cells in tendon and may have the chance of dis-
tinguishing different stem cell populations. Given that the
technique’s limitations are recognized, the combined use
of transgenic animals with cells labeled in different colors
and cell transplantation may also be useful for tracing
stem/progenitor cells in situ.
Conclusion
There is a huge need for specific and reliable markers
that can label TDSCs in vitro and tendon stem cells in
situ. Many of the existing markers seen as defining
MSCs are simply widely shared and expressed by fibro-
blasts, and hence these markers do not imply any true
in vivo stem cell property that defines true stem cells.
Better understanding of in vivo functions of common
MSC and ESC markers is important for identifying
markers associated with stemness (that is, self-renewal
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protein profiling may be useful for identifying markers
that can distinguish TDSCs from other cells. The
characterization of TDSCs and their subpopulations
using hierarchical markers should be one research direc-
tion. Researchers should be aware of the influence of cell
source, procedures of cell isolation and cell culture on
marker expression and hence the functions of TDSCs.
Standardization of TDSC and tenocyte culture in different
laboratories will facilitate the identification of TDSC-
specific markers. Markers that are used for the identifica-
tion of TDSCs in vitro may not be useful for tracking of
tendon stem cells in situ. Studies on tendon development
might help in the discovery of specific markers for tracing
tendon stem cells in situ.
Additional file
Additional file 1: Contains Table S1 and Table S2 presenting
protein expression of positive and negative markers in TDSCs
isolated from different tendons in different species.
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